DSV Panalpina A/S
Company Announcement No. 872
On 29 October 2020, we initiated a share buyback programme of DKK 6,000 million running until 30 April 2021, as described in Company Announcement No. 842. On 10 February 2021 the maximum aggregate purchase price of the shares to be bought back under the programme was increased to DKK 8,000 million.
According to the programme, the company will in the period from 29 October 2020 to 30 April 2021 purchase own shares up to a maximum value of DKK 8,000 million and no more than 12 million shares, corresponding to 5.22% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.
Trading day | Number of shares bought back | Average transaction price | Amount DKK | ||||
Accumulated trading for days 1-88 | 5,368,606 | 1,033.32 | 5,547,468,513 | ||||
89: | 8 March 2021 | 64,545 | 1,100.75 | 71,047,767 | |||
90: | 9 March 2021 | 50,000 | 1,135.68 | 56,784,175 | |||
91: | 10 March 2021 | 60,000 | 1,153.33 | 69,199,548 | |||
92: | 11 March 2021 | 60,000 | 1,172.99 | 70,379,634 | |||
93: | 12 March 2021 | 60,000 | 1,158.80 | 69,528,252 | |||
Accumulated trading for days 1-93 | 5,663,151 | 1,039.07 | 5,884,407,888 |
As at today, DSV Panalpina A/S holds a total of 7,113,038 shares of a nominal value of DKK 1 in DSV Panalpina A/S, corresponding to 3.09% of the total number of issued shares of 230,000,000.
The details of each transaction made under the share buyback programme are published on investor.dsv.com.
Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.
Yours sincerely,
DSV Panalpina A/S
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom